Previously described IL-12Rβ1 mutations in patients with MSMD are usually coupled to complete loss of IL-12Rβ1 expression, which was not seen in any of the patients in this study [30, 39]. Here, IL12RB1 is linked to Mendelian susceptibility to mycobacterial diseases.